Calcium-calcineurin signaling pathway in Candida albicans: A potential drug target

Microbiol Res. 2021 Aug:249:126786. doi: 10.1016/j.micres.2021.126786. Epub 2021 May 5.

Abstract

Increased morbidity and mortality of candidiasis are a notable threat to the immunocompromised patients. At present, the types of drugs available to treat C. albicans infection are relatively limited. Moreover, the emergence of antifungal drug resistance of C. albicans makes the treatment of C. albicans infection more difficult. The calcium-calcineurin signaling pathway plays a crucial role in the survival and pathogenicity of C. albicans and may act as a potential target against C. albicans. In this review, we summarized functions of the calcium-calcineurin signaling pathway in several biological processes, compared the differences of this signaling pathway between C. albicans and humans, and described anti-C. albicans activity of inhibitors of this signaling pathway. We believe that targeting the calcium-calcineurin signaling pathway is a promising strategy to cope with C. albicans infection.

Keywords: Antifungal targets; Calcium-calcineurin signaling pathway; Candida albicans.

Publication types

  • Review

MeSH terms

  • Antifungal Agents / pharmacology*
  • Antifungal Agents / therapeutic use
  • Calcineurin / metabolism*
  • Calcium / metabolism*
  • Calcium Signaling* / drug effects
  • Candida albicans / drug effects*
  • Candida albicans / metabolism*
  • Candidiasis / drug therapy
  • Candidiasis / microbiology
  • Fungal Proteins / antagonists & inhibitors
  • Fungal Proteins / metabolism
  • Humans

Substances

  • Antifungal Agents
  • Fungal Proteins
  • Calcineurin
  • Calcium